SLU-PP-332, as a novel small molecule compound, has shown great potential as a peripheral estrogen receptor (ERR) agonist in the treatment of metabolic diseases, improvement of muscle function, and other fields. Among the different dosage forms of SLU-PP-332, capsules and freeze-dried powder are the two common forms. Taking into account various factors, SLU-PP-332 capsules are significantly superior to freeze-dried powder in terms of ease of use, absorption efficiency, and stability. However, the poor water solubility and difficulty in absorption of freeze-dried powder limit its widespread application.

1.General Specification(in stock)
(1)API(Pure powder)
(2)Tablets
(3)Capsules
(4)Injection
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: BM-6-012
4-hydroxy-N'-(2-naphthylmethylene)benzohydrazide CAS 303760-60-3
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide tetracaine powder, please refer to the following website for detailed specifications and product information.
https://www.bloomtechz.com/oem-odm/capsule-softgel/slu-pp-332-capsules.html
SLU-PP-332 capsules have extremely high ease of administration. Capsule dosage form encapsulates drug powder or particles in a shell made of gelatin or other materials, and only needs to be taken with water. This design makes medication easy to carry, and patients can easily take their medication on time whether they are at home, traveling, or working or studying. For example, for patients who need to take SLU-PP-332 for a long time to improve metabolic status or enhance muscle function, the portability of the capsule allows them to take the medication anytime and anywhere, without affecting the treatment process due to environmental limitations.


In contrast, the process of using freeze-dried powder is more complicated. Taking common freeze-dried powder products as an example, they are usually packaged in penicillin bottles, and one bottle of freeze-dried powder needs to be used with one bottle of solvent. If it cannot be used up in one go after opening, it is necessary to cover it with a rubber head and refrigerate it in the refrigerator, and use it up within 3 days. When using, the freeze-dried powder and solvent should be mixed first, and the mixed freeze-dried powder should be used up within a certain period of time. This complex operation process not only increases the inconvenience for patients to use, but also easily leads to drug waste or affects the efficacy due to improper operation. For example, when mixing freeze-dried powder and solvent, if the ratio is inaccurate or the mixture is uneven, it may affect the absorption and therapeutic effect of the drug.
Capsule formulations perform well in terms of dosage accuracy. During the production process, drugs are precisely filled into capsules, and the dosage of drugs contained in each capsule is fixed. Patients only need to take the corresponding amount of capsules according to the doctor's advice to accurately obtain the required medication dosage, which is beneficial for the control and treatment of the condition. For example, in the treatment of obesity or metabolic syndrome, doctors will develop precise medication doses based on the patient's specific situation. Patients will take the capsules according to their specifications, which can ensure that the medication dose taken each time is accurate and correct, thereby improving the treatment effect.
When using freeze-dried powder, patients need to mix it with the solvent themselves, which poses a certain risk of dosage error. For example, during the mixing process, uneven drug concentration may occur due to unskilled operation or inaccurate measurement, which can affect the therapeutic effect. Especially for some diseases that require strict control of drug dosage, this dosage error may have serious consequences. For example, in the treatment of non-alcoholic fatty liver disease, if the drug dosage is not accurate, it may not effectively reduce the liver fat content and affect the improvement of the condition.
SLU-PP-332 capsules have good stability. The capsule shell can effectively protect drugs from external environmental factors such as light, air, moisture, etc. During storage and transportation, capsules can maintain the chemical and physical stability of drugs, extending their shelf life. Taking the storage conditions of SLU-PP-332 as an example, it is recommended to store its powder form in a sealed, dry, room temperature, and place without direct sunlight. After being made into capsules, it can better adapt to different storage and transportation environments. For example, during long-distance transportation, capsules can prevent a decrease in drug quality due to changes in temperature, humidity, and other factors.
In contrast, although freeze-dried powder also removes moisture and improves the stability of the drug through freeze-drying technology, the stability of the drug will be affected once mixed with the solvent during use. The mixed solution needs to be used up within a certain period of time, otherwise the efficacy may be reduced due to microbial contamination or drug degradation. For example, if the freeze-dried powder solution is contaminated with bacteria during storage, the drug may deteriorate, not only failing to achieve therapeutic effects, but also posing a risk to the patient's health.
Capsule formulations also have certain advantages in terms of absorption efficiency. Taking some specially designed capsules as an example, they use patented capsule coating technology that is resistant to stomach acid and bile, ensuring that the drug maintains high activity during targeted release in the intestine. For example, some probiotic capsules use this technology to allow probiotics to survive in large quantities and reach the gut after passing through the environment of stomach acid and bile, playing a role in regulating the gut microbiota. For SLU-PP-332 capsules, similar techniques may also help improve the absorption of drugs in the intestine, enabling drugs to better activate the ERR signaling pathway and regulate energy metabolism.
Due to poor water solubility, freeze-dried powder is subject to certain limitations during absorption. SLU-PP-332 pure product is insoluble in water. Although it has some solubility in certain solvents, its solubility in water is poor. The poor water solubility of freeze-dried powder requires the use of specific solvents for dissolution, which increases the complexity and cost of use. Moreover, even with solvent dissolution, the ideal dissolution state may not be fully achieved, affecting the absorption and utilization of the drug. For example, in terms of skin absorption, although some skincare products claim to use special techniques to promote absorption, in reality, intact skin can only absorb a small amount of water and trace gases, and water-soluble substances themselves are not easily absorbed. Even after treatment, the absorption effect of freeze-dried powder is difficult to achieve the ideal level. In terms of oral administration, the dissolution and absorption process of freeze-dried powder in the gastrointestinal tract may also be affected by its water solubility, which may lead to a decrease in the bioavailability of the drug and prevent it from fully exerting its efficacy.
Difficulties in water solubility and absorption of freeze-dried powder
SLU-PP-332 pure product is insoluble in water due to its chemical properties. Its molecular structure makes it difficult to form a stable dissolved state in water. Although it has some solubility in organic solvents such as DMSO and ethanol, its solubility in water is extremely poor. This chemical property results in a natural disadvantage of freeze-dried powder in terms of water solubility. For example, when preparing freeze-dried powder solutions, specific solvents need to be used to dissolve the freeze-dried powder, and even if solvents are used, they may not be completely dissolved, resulting in precipitation or stratification, which affects the effectiveness of drug use.
Overall, SLU-PP-332 capsules have significant advantages in terms of ease of administration, dosage accuracy, stability, and absorption effect, which can better meet the medication needs of patients. However, freeze-dried powder faces many challenges in practical applications due to poor water solubility and limited absorption efficiency. Therefore, in terms of dosage form selection for SLU-PP-332, capsule dosage form is more recommended. Of course, with the continuous advancement of technology, it is also expected that in the future, the water solubility and absorption effect of freeze-dried powder can be improved by improving the preparation process of freeze-dried powder and developing new solvents, so as to play a greater role in the pharmaceutical field. But at this stage, SLU-PP-332 capsules are undoubtedly a better choice.




